U.S. bond funds gain inflows for fourth week in a row



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>GRAPHIC-U.S. bond funds gain inflows for fourth week in a row</title></head><body>

Feb 3 (Reuters) -U.S. bond funds drew money inflows for a fourth straight week in the seven days to Feb. 1, on hopes of slowing rate hikes, with its economy grappling against a slowdown.

Refinitiv Lipper data showed investors purchased a net $197 million worth of U.S. bond funds, although a big drop from the previous week's $4.84 billion worth of net purchases.

The Fed lifted its key overnight lending rate to a range of 4.5% to 4.75% in a widely expected move on Wednesday, but Fed Chair Jerome Powell appeared to strike a more dovish tone in a press conference.nL1N34I02R

Investors purchased $438 million worth of municipal bond funds, but U.S. taxable bond funds witnessed $252 million worth of outflow, the first weekly net selling in five weeks.

U.S. short/intermediate investment-grade funds received $2.81 billion worth of inflows, the biggest amount in three weeks, while U.S. emerging markets debt funds had $273 million worth of net buying.

Meanwhile, U.S. equity funds' outflows cooled to an 11-week low of $483 million amid $584 million worth of net purchases in small-cap funds. However, large- and mid-cap funds had outflows of $3.67 billion and $206 million, respectively.

Investors sold tech and real estate sector funds of $261 million and $248 million, respectively, but energy funds drew $436 million worth of inflows.

Meanwhile, money market funds attracted $122 million, marking a second straight week of inflow.



Fund flows: US equities, bonds and money market fundshttps://tmsnrt.rs/3jrjrED

Fund flows: US bond fundshttps://tmsnrt.rs/3JA4Ph1

Fund flows: US equity sector fundshttps://tmsnrt.rs/40uTNPZ


Reporting by Gaurav Dogra and Patturaja Murugaboopathy in Bengaluru; Editing by Ben Dangerfield

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.